HEALTHCARE RESOURCE UTILIZATION AND COSTS OF MYOTUBULAR MYOPATHY IN ENGLAND

被引：0
|
作者：
Khan, A. [1 ]
Stoelzel, M. [2 ]
Rozario, N. [3 ]
Jungbluth, H. [4 ]
Pinedo-Villanueva, R. [5 ]
Kiran, A. [6 ]
机构：
[1] Astellas Gene Therapies, San Francisco, CA USA
[2] Astellas Pharma Europe BV, Leiden, Netherlands
[3] Astellas Pharma US, Northbrook, IL USA
[4] Evelina Childrens Hosp, London, England
[5] Univ Oxford, Oxford, England
[6] Astellas Pharma Europe Ltd, Addlestone, Surrey, England
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE221
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [1] Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States
    Graham, Robert J.
    Darras, Basil T.
    Haselkorn, Tmirah
    Fisher, Dan
    Genetti, Casie A.
    Miller, Weston
    Beggs, Alan H.
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [2] HEALTHCARE RESOURCE USE AND EXPENDITURES IN PATIENTS WITH X-LINKED MYOTUBULAR MYOPATHY (XLMTM)
    Sacks, N.
    Healey, B. E.
    Cyr, P. L.
    Slocomb, T.
    James, E. S.
    Beggs, A. H.
    Graham, R. J.
    VALUE IN HEALTH, 2020, 23 : S331 - S331
  • [3] Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States
    Robert J. Graham
    Basil T. Darras
    Tmirah Haselkorn
    Dan Fisher
    Casie A. Genetti
    Weston Miller
    Alan H. Beggs
    Orphanet Journal of Rare Diseases, 18
  • [4] HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH CERVICAL DYSTONIA
    Hull, M.
    Anupindi, R.
    He, J.
    Danchenko, N.
    DeKoven, M.
    Bouchard, J.
    VALUE IN HEALTH, 2022, 25 (01) : S106 - S106
  • [5] MYOTUBULAR MYOPATHY
    KINOSHITA, M
    CADMAN, TE
    ARCHIVES OF NEUROLOGY, 1968, 18 (03) : 265 - +
  • [6] MYOTUBULAR MYOPATHY
    BADURSKA, B
    FIDZIANSKA, A
    KAMIENIECKA, Z
    PROT, J
    STRUGALSKA, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1969, 8 (03) : 563 - +
  • [7] Healthcare resource utilization and costs associated with anogenital warts in Morocco
    Berrada, Myriam
    Holl, Ryan
    Ndao, Tidiane
    Bencina, Goran
    Dikhaye, Siham
    Melhouf, Abdelilah
    Chiheb, Soumiya
    Guelzim, Khalid
    INFECTIOUS AGENTS AND CANCER, 2021, 16 (01)
  • [8] Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
    Eric Surrey
    Ahmed M. Soliman
    Helen Trenz
    Cori Blauer-Peterson
    Ashley Sluis
    Advances in Therapy, 2020, 37 : 1087 - 1099
  • [9] Healthcare Resource Utilization and Costs of Multiple Sclerosis in Canada by Disability
    Metz, Luanne
    Greenfield, Jamie
    Marrie, Ruth-Ann
    Jette, Nathalie
    Suchowersky, Oksana
    Svenson, Larry
    Alikhani, Katayoun
    Khan, Maheer
    Gholizadeh, Shervin
    Xue, Cloris
    NEUROLOGY, 2017, 88
  • [10] HEALTHCARE RESOURCE UTILIZATION AND COSTS OF CARE FOR MESOTHELIOMA MEDICARE BENEFICIARIES
    Fryzek, J.
    Ruterbusch, J. J.
    Garabrant, D. H.
    Dalvi, T.
    Beebe-Dimmer, J.
    VALUE IN HEALTH, 2017, 20 (05) : A353 - A353
12345